Our Tech
InSight revolutionizes the way drug discovery and development is conducted. Through specialized protocols for human donor eye transportation, specimen incubation, and data acquisition, we are able to provide relevant safety and efficacy metrics through light signaling and molecular biomarkers. These metrics reduce reliance on inadequate animal models while improving the relevance of preclinical test results, which translates to an improved clinical success rate.
Human Donor Eye Transportation
Infrastructure and scientifically demonstrated technology and protocols for transportation of the human eyes while reviving and preserving their ability to generate and transmit light signals.
Donor Eye and Human Retina Preservation
Technology and protocols for long-term preservation of in-vivo like light responsiveness of the human eyes.
Data Collection
Technology and protocols for precise sample collection (central vs peripheral; diseased vs healthy region of the human retina), electrophysiological recordings, basic molecular and cell biology experiments, injury/disease models and drug or gene therapy testing, analysis and interpretation.